Patent · US Active

HNF4a saRNA compositions and methods of use

US11965163B2 · kind B2 · utility

0Cited by

5References

12Claims

0Family size

Assignee

MiNA Therapeutics Limited · GB

Inventors

Hans E. Huber · Lansdale, US
David Charles Blakey · Macclesfield, GB
Jon Voutila · London, GB
Monika Krampert · Bamberg, DE
Markus Hossbach · Kulmbach, DE

Key dates

Filing date	Sep 28, 2021
Grant date	Apr 23, 2024
Priority date	—
Expiry date	Oct 31, 2041

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2320/32
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to saRNA targeting an HNF4a transcript and therapeutic compositions comprising said saRNA. Methods of using the therapeutic compositions are also provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.